eikance 0.01% atropine sulfate monohydrate 100 microgram/1 ml eye drops solution packed in single-dose ampoules
aspen pharmacare australia pty ltd - atropine sulfate monohydrate, quantity: 0.1027 mg/ml (equivalent: atropine sulfate, qty 0.1 mg/ml) - eye drops, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - eikance 0.01% is indicated as a treatment to slow the progression of myopia in children aged from 4 to 14 years. atropine treatment may be initiated in children when myopia progresses greater than or equal to -1.0 d per year.
sodium cromoglicate
norton healthcare limited t/a ivax pharmaceuticals uk - cromoglicate sodium - eye drops solution - 2 %w/v
vividrin preservative free sdu 2% w/v eye drops solution
bausch health ireland limited - sodium cromoglycate - eye drops, solution - 2 percent weight/volume - other antiallergics; cromoglicic acid
cromolux
aft pharmaceuticals ltd - sodium cromoglicate 2%{relative} - eye drops, solution - 2% w/v - active: sodium cromoglicate 2%{relative} excipient: benzalkonium chloride edetic acid purified water
minims saline 0.9% eye drops 0.5ml unit dose
bausch & lomb uk ltd - sodium chloride - eye drops - 9mg/1ml
minims saline 0.9% w/v eye drops, solution
bausch + lomb ireland limited - sodium chloride - eye drops, solution - other antiinfectives; zinc compounds
minims lidocaine (lignocaine) 4% and fluorescein 0.25% eye drops tube
bausch & lomb australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 40 mg/ml; fluorescein sodium, quantity: 2.5 mg/ml - eye drops, solution - excipient ingredients: purified water; hydrochloric acid; povidone - as a diagnostic stain and topical anaesthetic combined, minims lignocaine and fluorescein is intended primarily to facilitate goldmann applanation tonometry.
mydriacyl tropicamide 1% eye drops bottle
alcon laboratories australia pty ltd - tropicamide, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; benzalkonium chloride; purified water; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at 14 july 2003 : used to produce mydriasis and cycloplegia for diagnostic purposes.
maxidex dexamethasone 0.1% eye drops bottle
novartis pharmaceuticals australia pty ltd - dexamethasone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: dibasic sodium phosphate; polysorbate 80; disodium edetate; sodium chloride; benzalkonium chloride; purified water; hypromellose; citric acid monohydrate; sodium hydroxide - indications as at 16 jan 2005 : steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in oedema and inflammation; acute and chronic anterior uveitis; corneal injury from chemical radiation or thermal burns or penetration of foreign bodies.
prednefrin forte phenylephrine hydrochloride/prednisolone acetate eye drops bottle
abbvie pty ltd - phenylephrine hydrochloride, quantity: 1.2 mg/ml; prednisolone acetate, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: benzalkonium chloride; sodium metabisulfite; sodium citrate dihydrate; sodium chloride; boric acid; hypromellose; disodium edetate; phenazone; polysorbate 80; purified water; hydrochloric acid; sodium hydroxide - severe inflammation (non-infectious) of the eye, such as acute iritis, iridocyclitis, scleritis, episcleritis, uveitis, resistant ocular allergy and inflammation following surgery (where no infectious aetiology is suspected), particularly where unusually rapid control of the inflammation is required.